Profile
VTGN VRTX ALNY REGN ARGX SGEN
Company Name VistaGen Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $88.97M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.05K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Shawn K. Singh Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
VTGN VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
VTGN VRTX ALNY REGN ARGX SGEN
Last Close $2.9 $387.15 $451.725 $585.5 $734.35 $228.74
High 52 $3.69 $516.74 $482.13 $1150.19 $768 $228.74
Low 52 $1.96 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -21.41 % -25.08 % -6.31 % -49.1 % -4.38 % 0 %
Price vs. 52 Week Low 47.96 % 5.62 % 101.14 % 21.24 % 41.29 % 0 %
Total Return
VTGN VRTX ALNY REGN ARGX SGEN
1 Month Return -14.71 % -0.7 % -1.13 % 2.04 % 11.04 % 0 %
3 Month Return 40.78 % -13.66 % 44.64 % 14 % 36.52 % 0 %
6 Month Return 7.41 % -24.42 % 84.91 % -11.98 % 20.15 % 0 %
9 Month Return 25 % -13.49 % 89.86 % -18.07 % 17.65 % 0 %
YTD Return -1.69 % -3.86 % 91.97 % -17.8 % 19.41 % 0 %
1 Year Return -3.17 % -18.35 % 65.38 % -48.59 % 38.8 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VTGN VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -1088.57 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
VTGN VRTX ALNY REGN ARGX SGEN
Asset Growth -31.79 % -0.87 %
Gross Profit Growth -54.32 % 10.25 %
Revenue Growth -54.32 % 11.66 %
Revenue 3 Year -90.58 % 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -69.51 % -93.69 %
Net Income Growth -75.12 % -114.8 %
Net Income 3 Yeari Growth Per Share 76.87 % -122.89 %
Net Income 5 Yeari Growth Per Share 88.21 % -145.38 %
Net Income 10 Yeari Growth Per Share 99.47 % 33.84 %
Operating Income Growth -69.51 % -106.08 %
Operating Cash Flow Growth (CFG) -63.08 % -113.93 %
Operating 3 Year CFG 80.01 % -118.65 %
Operating 5 Year CFG 87.28 % -131.3 %
Operating 10 Year CFG 97.84 % 12.43 %
EPS Growth -9.87 % -114.8 %
EPS Diluted Growth -9.87 % -114.97 %
Book Value Per Share -61.19 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -76.63 % 62.6 %
Share Holder 5 Year Equity Growth Per Share 158.5 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 100.49 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share -100 % -
Dividend 5 Year Growth Per Share -100 % -
Dividend 10 Year Growth Per Share - -
Debt Growth -28.82 % 116.42 %
Free Cash Flow Growth -63.44 % -124.1 %
Updated On 31 Mar 2025 31 Dec 2024
Profitability
VTGN VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 73.84 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -80.93 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -74.06 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -103.25 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100.01 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 93.51 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -9233.13 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -2125.38 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 1.33 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 37.21 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 0.94 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -1.57 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -1.57 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 197.87 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -7751.39 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.09 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -2125.38 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -1.78 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -1.85 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -1.85 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
VTGN VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.06B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.05B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -1.67 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
VTGN VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.01B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.07B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0.01B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.08B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
VTGN VRTX ALNY REGN ARGX SGEN
Net Income $-0.05B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.04B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.95
AARD Aardvark Therapeutics, Inc. Common Stock 10.97
ABCL AbCellera Biologics Inc. 4.57
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.64
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.25
ABPWW 0.046281
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 4.43
ABVC ABVC BioPharma, Inc. 2.86
ABVX Abivax SA American Depositary Shares 81
ACAD ACADIA Pharmaceuticals Inc. 24.2
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7602
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.96
ACIU AC Immune SA 2.46
ETFs With Exposure to VTGN
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0 238.89
VTI Vanguard Total Stock Market Index Fund 0.0002 325.16
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 143.92
IWN iShares Russell 2000 Value ETF 0 175.07
IWV iShares Russell 3000 ETF 0 374.38
IWO iShares Russell 2000 Growth ETF 0 315.01
VXF Vanguard Extended Market Index Fund 0.00113 209.29
HDG ProShares Hedge Replication ETF 0 51.245
UWM ProShares Ultra Russell2000 0 45.52
IWC iShares Micro-Cap ETF 0.02251 146.1
URTY ProShares UltraPro Russell2000 0 51.54
BTEC Principal Healthcare Innovators ETF 0.04 39.49
VFLQ Vanguard U.S. Liquidity Factor ETF 0.14 99.7611
VTWG Vanguard Russell 2000 Growth Index Fund 0.02 230.232
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.0001 110.6
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 110.58
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.41
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.4
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.4
RYLD Global X Russell 2000 Covered Call ETF 0 15.27
DFAT Dimensional U.S. Targeted Value ETF 0.00007553 58.69
VTSAX Vanguard Total Stock Market Index Fund 0 158.29
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.0012 158.73
VITSX Vanguard Total Stock Market Index Fund 0 158.32
IBRN iShares Neuroscience and Healthcare ETF 0.15483 25.5232
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000385176 15.99
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.0012 158.74
SWSSX Schwab Small-Cap Index Fund-Select Shares 0 38.95
JKK iShares Morningstar Small-Cap Growth ETF 0.02 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0.01 57.31
PSIL AdvisorShares Psychedelics ETF 4.64 16.87
VTS.AX Vanguard US Total Market Shares Index ETF 0.0002 493.31
VEMPX Vanguard Extended Market Index InstlPlus 0.0012 391.73
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00017 296.99
Unlock